Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Hair loss is a common side effect of hormone treatments for cancer.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride caused serious side effects and led to six suicides.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

New treatments for male hypogonadism are effective and should be personalized.

Hair Tonic A, with white tea extract, is better for improving hair health.

Finasteride may increase suicide risk; more research needed.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.